Sad Daughter Hugging Her Mother

Not Your Grandmother’s Disease: The Truth about Early-Onset Alzheimer’s

Early-onset Alzheimer’s is a form of dementia that occurs in individuals younger than the age of 65. Of all the people that are affected by Alzheimer’s disease, only five percent develop symptoms before age 65. While this may seem like an insignificant number, over 4 million Americans are currently battling Alzheimer’s, meaning at least 200,000…

Schizophrenia Treatment Research

Cannabidiol May be a New Method for Treating Schizophrenia

Researchers have recently made some groundbreaking developments in the exploration of possible treatments of Schizophrenia. The research was conducted by Illawarra Health and Medical Research Institute (IHMRI) in New South Wales, Australia. The team’s unique approach to combating schizophrenia is through the use of a cannabis compound called cannabidiol. This is in an effort to combat the ineffectiveness of current medicine designed for schizophrenia treatment.

Research Needed for Ketamine Use for Depression Therapy

While commonly used as an anesthetic and pain reliever, Ketamine is likely more famous as an illicit party drug, better known as K or Special K, sometimes referred to as cat or horse tranquilizers. Partially because of this negative association, many are skeptical of its viability as a valid medical treatment for depression, a use several doctors and researchers have been advocating for years.

ISU Alzheimer’s Study Links Family History to Gene Behavior

A recent study conducted by researchers at Iowa State University may have identified the missing link between a metabolic gene and Alzheimer’s Disease, a connection that has eluded scientists for years. Led by Auriel Willette, an assistant professor of food science and human nutrition, the study concluded that family history can alter the behavior of TOMM40, explaining inconsistencies in previous research.